Amarantus Bioscience Holdings Inc (AMBS)

[av1atic]

Couple questions someone with the username "coldcoffee123" asked on SA in regards to an article written by Jason about Lympro. Any opinions/answers to these questions? Just curious:

According to my sources, BD LymPro results have come out of negative. They will not be receiving any funding from BD for CLIA. That is the reason why AMBS had to raise $3M immediately. Expect the stock to trade around $0.035 range later this week.

Any idea why nobody is ready to fund AMBS's research? With Rubinfeld on board, can he not drop a word or two to Amgen? Amgen can spend 11B for Onyx, but nothing for AMBS? They can buy AMBS Diagnostics+Therapeutics for dirt cheap and it could turn out to be great investment. Surely somebody must be eyeing AMBS, don''t you think?? Hard to believe Big Pharma that are always scouting for golden opportunities for acquisition are turning a blind eye to AMBS. Could it be that AMBS is a scam?

Some of the recent peer-reviewed publications are coming from independent groups working on MANF. How does their success (for whatever indications they are researching on) help AMBS? For example, lets suppose one of these research groups manages to get orphan designation for Fairbanks. How does that help AMBS, other than the fact that it involves MANF? How does MANF patents benefit AMBS for research that is not directly being done by AMBS? Will these groups be required to pay anything to AMBS? Can they refuse to do so? Sorry, I have no idea how patents work !

http://seekingalpha.com/article/1347691-amarantus-lympro-could-be-a-game-changer-for-alzheimers-diagnosis?v=1376321454&source=tracking_notify